CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,000 | -28.6% | 16,600 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +40.0% | 16,600 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | +25.0% | 16,600 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -90.0% | 16,600 | -55.7% | 0.00% | – |
| Q1 2019 | $40,000 | -39.4% | 37,458 | -1.8% | 0.00% | – |
| Q4 2018 | $66,000 | -70.8% | 38,152 | -2.0% | 0.00% | – |
| Q3 2018 | $226,000 | +40.4% | 38,934 | +4.0% | 0.00% | – |
| Q2 2018 | $161,000 | -93.3% | 37,444 | -90.9% | 0.00% | – |
| Q1 2018 | $2,420,000 | +30.0% | 411,838 | +2.3% | 0.00% | – |
| Q4 2017 | $1,861,000 | -8.9% | 402,414 | +8.1% | 0.00% | – |
| Q3 2017 | $2,042,000 | -2.4% | 372,111 | +2.6% | 0.00% | – |
| Q2 2017 | $2,092,000 | +460.9% | 362,811 | +690.3% | 0.00% | – |
| Q1 2014 | $373,000 | +30.4% | 45,906 | +3.6% | 0.00% | – |
| Q4 2013 | $286,000 | -24.9% | 44,293 | +16.9% | 0.00% | – |
| Q3 2013 | $381,000 | – | 37,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |